NextCure, Inc.NXTCNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank50
3Y CAGR+14.6%
5Y CAGR-17.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+14.6%/yr
vs +31.2%/yr prior
5Y CAGR
-17.4%/yr
Recent acceleration
Acceleration
-16.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.77M-56.7%
2024$4.09M-16.7%
2023$4.91M+317.9%
2022$1.18M-14.5%
2021$1.38M-70.2%
2020$4.62M+23.4%
2019$3.75M+843.3%
2018$397000.00+396.3%
2017$80000.00-